Stam F, Stehouwer C D
Afd. Inwendige Geneeskunde, Academisch Ziekenhuis Vrije Universiteit, Amsterdam.
Ned Tijdschr Geneeskd. 1992 Nov 21;136(47):2336-8.
This article presents the clinical history of a man aged 64 who developed Henoch-Schönlein purpura after administration of streptokinase for acute myocardial infarction. Because of the increasing use of streptokinase it is assumed that type III hypersensitivity reactions to streptokinase will be seen more frequently. The first symptoms may arise after discharge from the hospital, as symptom-free periods of 3 to 21 days have been reported.
本文介绍了一名64岁男性的临床病史，该患者在因急性心肌梗死接受链激酶治疗后发生了过敏性紫癜。由于链激酶的使用日益增多，推测对链激酶的III型超敏反应将更频繁地出现。首发症状可能在出院后出现，因为已有报告称无症状期为3至21天。
